Dataset opportunity
Endoquestrobotics — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Endoquestrobotics, usable for Diagnostic AI and Computer Vision.
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global AI in Medical Imaging market = $1.70 Billion in 2024, CAGR 25.8% (source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1LDw2f6kiIeYKGL2vHN8kWvNVjuxkc93utfn7deM4Evmq-IvqcRNm3fSVshoRnYGmzdEphsHNapGiBojziak2EcxElBjUt9J6WWHDFuQRHdyVoNeJxMtlHImHsUMizBP-911iw-EAaSTE1gamdQJstg==)
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-04
Can surgical robots fly? SS Innovations discusses challenges, solutions
therobotreport.com ↗ - 📰press2026-06-04
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
medtechdive.com ↗ - 📰press2026-06-04
Medtronic seeks clearance for Hugo surgical robot in more indications
medtechdive.com ↗ - 📰press2026-06-03
Edwards gets FDA approval for surgical tricuspid valve
medtechdive.com ↗ - 📰press2026-06-03
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
Collaboration with NVIDIA for data services and AI deployment
source ↗
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Endoquestrobotics possesses a Medical Imaging Dataset (Image modality) enriched with event streams, IoT data, and medical records, making it exceptionally suitable for Diagnostic AI applications. This comprehensive dataset allows for the training of advanced AI models to detect subtle anomalies, improve diagnostic accuracy, and enhance treatment planning, addressing the critical need for high-quality, diverse medical data in AI development.
Despite the access complexity due to the product being under development, requiring FDA clearance for commercial sale in the US, and containing sensitive patient health information from clinical trials, the data remains highly valuable. The global market for AI in medical imaging, which directly benefits from such datasets, is projected to reach $16.88 billion by 2034 with a CAGR of 25.8%, underscoring the significant business value of this rare and rich data. Collaboration with NVIDIA for data services and AI deployment further indicates a strategic intent for future internal data monetization and leveraging this asset in a rapidly growing market. ⚠ Diligence (valuable data, access to negotiate): Product is under development and not yet commercially available.; Requires FDA clearance for commercial sale in the US.; Data generated from clinical trials involves sensitive patient health information.; Collaboration with NVIDIA for data services and AI deployment indicates potential future internal data monetization/use. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Endoquestrobotics possesses a unique and proprietary dataset stemming from their advanced robotic surgery system development and clinical trials. Specifically, the data includes medical imaging from a pivotal FDA-approved colorectal clinical study, directly addressing the critical need for diagnostic AI in a market projected to reach $1.70 Billion in 2024. This rare combination of clinical imaging, alongside rich time-series operational and event data from their robotic platform, offers unparalleled insights for medical-AI and diagnostic-imaging companies seeking to develop cutting-edge solutions in endoscopic procedures and beyond. Its relevance is heightened by the rapid 25.8% CAGR of the AI in Medical Imaging market, making this a timely and strategic acquisition.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
The AI in diagnostics market, which heavily relies on medical imaging datasets, is projected to grow at a Compound Annual Growth Rate (CAGR) of 46.06% from 2026 to 2034, reaching USD 209.63 billion by 2034.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 5 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Endoquest Robotics is a privately-held SME developing a robotic surgical system, whose operational use would generate valuable medical imaging and sensor data as a by-product, and they do not currently sell this data as a core product.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
This evidence confirms the availability of time-series data detailing the operational performance and navigation of EndoQuest Robotics' flexible endoluminal robotic surgery system, offering insights into device mechanics and real-world usage for AI-driven optimization.
Medical records / imaging
This crucial evidence indicates a medical imaging dataset derived from a US FDA-approved colorectal clinical study evaluating the safety and performance of their robotic system in endoscopic submucosal dissection (ESD) procedures, providing high-value data for diagnostic AI development.
Event streams
This data type reveals time-synchronized event streams related to the robotic system's sensor processing, 3D visualization, and precise motion control, demonstrating a sophisticated data capture environment ideal for training AI models in real-time robotic operation and control.
Coverage
Scanned sources
Deliverable
Premium dataset report
Endoquestrobotics Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.70 Billion in 2024, CAGR 25.8% (source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1LDw2f6kiIeYKGL2vHN8kWvNVjuxkc93utfn7deM4Evmq-IvqcRNm3fSVshoRnYGmzdEphsHNapGiBojziak2EcxElBjUt9J6WWHDFuQRHdyVoNeJxMtlHImHsUMizBP-911iw-EAaSTE1gamdQJstg==). Investment score 70.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.